ESCMID weekly news 19.09.2023

Weekly News

Having trouble viewing this email? View in your browser.

WEEKLY NEWS

19 September 2023

Apply now for the ESCMID Foerderverein Grant

The Foerderverein Grant will again be used to support ECCMID attendees active in Clinical Microbiology and Infectious Diseases and residing or working in Low- and Lower-Middle Income Countries (LMICs). Selected grantees will receive free registration to ECCMID 2024 as well as having their flights and accommodation paid for. Detailed requirements can be found at the Awards & Grants tab on the ECCMID webpage - deadline to apply is 29 September 2023.

IMPORTANT DATES AND DEADLINES

29 September 2023 | Deadline

Application for Foerderverein Grant

.

18 October 2023 | Deadline

Application for funded Observerships

.

25 October 2023 | Deadline

Application for ESCMID Awards

.

11 November 2023 | Deadline

ESCMID AMS Certificate application

Apply now for one of the ESCMID Awards

ESCMID Awards acknowledge excellence and outstanding innovation by researchers, clinicians and other persons contributing to the progress of the fields of Clinical Microbiology and Infectious Diseases. These awardees are invited to give lectures at ECCMID and are eligible to become ESCMID Fellows. Calls to apply will close on 25 October 2023.

Register for the "Mastering Scientific Article Writing" webinar

Join us for a comprehensive online workshop that delves into the intricacies of crafting a compelling scientific article for publication in the journal Clinical Microbiology and Infection. Presented by the journal's experienced editors, Angela Huttner, Jesús Rodríguez-Baño, and Editor-in-Chief Leonard Leibovici, this workshop promises valuable insights and practical guidance to enhance your medical writing skills.

Register onsite or online now for this ESCMID hybrid course

Module Objectives: train and educate doctors, hospital pharmacists and healthcare providers interested in Antimicrobial Stewardship, on how to a) use appropriately antimicrobials in complicated infections, but also b) prevent and control infections, thus eliminating the need for the use of antimicrobials.

Unveiling the Future of AMR Solutions! ASM/ESCMID Conference on Drug Development starts today

Here's a sneak peek of the exceptional content awaiting you at ASM/ESCMID:
- Unlocking the power of artificial intelligence: revolutionise drug development with cutting-edge AI tools, accelerating the discovery of potent antimicrobial and antifungal agents for a healthier future!
- Phage therapy: harness the potential of phage therapy, a natural phenomenon, to combat AMR and offer hope against resistant pathogens!
- Equity and social justice: address healthcare disparities to empower the fight against AMR, fostering a fair and inclusive healthcare landscape for all!

Recording available of the joint ESCMID-IDSA webinar

If you missed this interesting live webinar last week, you can watch the recording on the ESCMID eAcademy. Speakers Tina Tan and Isabella Eckerle explored what we can expect as respiratory viruses begin to return with the cold weather and presented strategies for prevention.

The Effect of Antibiotic Therapy for Clostridioides difficile Infection on Mortality and Other Patient-Relevant Outcomes: a Systematic Review and Meta-analysis

EMA is looking for new data partners to collaborate with DARWIN EU® - the Data Analysis and Real-World Interrogation Network. Does your public or private institution have access to real-world healthcare data?

ESCMID Executive Office
Gerbergasse 14
4001 Basel
Switzerland

Phone +41 61 508 0150
info@escmid.org
www.escmid.org

.

The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program's address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.

.
. .
Nahoru